Journal Articles
2021
Lecavalier-Barsoum, Magali; Khosrow-Khavar, Farzin; Asiev, Krum; Popovic, Marija; Vuong, Te; Enger, Shirin A.
Utilization of brachytherapy in Quebec, Canada Journal Article
In: Brachytherapy, pp. S1538–4721(21)00452–9, 2021, ISSN: 1873-1449.
Abstract | Links | BibTeX | Tags: High dose rate brachytherapy, Interstitial brachytherapy, Intracavitary brachytherapy, Low dose rate brachytherapy, Number of brachytherapy treatments, Trends in utilization
@article{lecavalier-barsoum_utilization_2021,
title = {Utilization of brachytherapy in Quebec, Canada},
author = {Magali Lecavalier-Barsoum and Farzin Khosrow-Khavar and Krum Asiev and Marija Popovic and Te Vuong and Shirin A. Enger},
doi = {10.1016/j.brachy.2021.07.002},
issn = {1873-1449},
year = {2021},
date = {2021-08-01},
journal = {Brachytherapy},
pages = {S1538--4721(21)00452--9},
abstract = {BACKGROUND AND PURPOSE: Despite the excellent clinical outcomes from brachytherapy treatments compared with other modalities and the low associated costs, there have been reports of a decline in utilization of brachytherapy. The aim of this study was to investigate in detail the trend in utilization of brachytherapy in the province of Québec, Canada, from 2011 to 2019.
MATERIALS AND METHODS: All radiotherapy clinics in the province of Quebec, and among these the clinics that provide brachytherapy treatments, were identified. This observational retrospective cohort study involved analysis of data compiled by the Ministère de la Santé et des Services Sociaux du Québec for the period of 2011 to end of 2019 on all brachytherapy procedures performed in the province of Quebec. Time series graphs were used to describe the number of high dose rate (HDR) and low dose rate (LDR) brachytherapy treatments during the studied time period. Statistical analysis was conducted using R statistical software.
RESULTS: Between 2011 and 2019, 12 hospitals in the province of Québec provided radiotherapy treatments, and all of them offered brachytherapy services. The median annual number of brachytherapy sessions was 4413 (range 3930-4829). HDR brachytherapy represented over 90% of all brachytherapy treatments throughout the study period. Significant changes over time were observed in the number of treatments: at least 5% change was seen only for the two most common subtypes of brachytherapy, HDR interstitial and HDR intracavitary, with an increase of 9.6% and a decrease of 9.2%, respectively. The use of other subtypes of brachytherapy (HDR-plesiotherapy, LDR-interstitial, LDR-intracavitary, LDR-eye plaque) was stable between 2011 and 2019, with ≤ 2.5% variation.
CONCLUSION: This study demonstrates an overall steady use of brachytherapy between 2011 and 2019 in Quebec. Brachytherapy offers numerous advantages for the treatment of diverse cancer sites. Although more sophisticated external beam radiotherapy treatments have emerged in the last decades, the precision and cost-effectiveness of brachytherapy remain unbeaten. To ensure the continued use and availability of brachytherapy, governments must put in place policies and regulations to that effect. Training and exposure of future health care professionals to brachytherapy within Quebec and Canada is essential to provide all patients the same access to this life saving modality.},
keywords = {High dose rate brachytherapy, Interstitial brachytherapy, Intracavitary brachytherapy, Low dose rate brachytherapy, Number of brachytherapy treatments, Trends in utilization},
pubstate = {published},
tppubtype = {article}
}
BACKGROUND AND PURPOSE: Despite the excellent clinical outcomes from brachytherapy treatments compared with other modalities and the low associated costs, there have been reports of a decline in utilization of brachytherapy. The aim of this study was to investigate in detail the trend in utilization of brachytherapy in the province of Québec, Canada, from 2011 to 2019.
MATERIALS AND METHODS: All radiotherapy clinics in the province of Quebec, and among these the clinics that provide brachytherapy treatments, were identified. This observational retrospective cohort study involved analysis of data compiled by the Ministère de la Santé et des Services Sociaux du Québec for the period of 2011 to end of 2019 on all brachytherapy procedures performed in the province of Quebec. Time series graphs were used to describe the number of high dose rate (HDR) and low dose rate (LDR) brachytherapy treatments during the studied time period. Statistical analysis was conducted using R statistical software.
RESULTS: Between 2011 and 2019, 12 hospitals in the province of Québec provided radiotherapy treatments, and all of them offered brachytherapy services. The median annual number of brachytherapy sessions was 4413 (range 3930-4829). HDR brachytherapy represented over 90% of all brachytherapy treatments throughout the study period. Significant changes over time were observed in the number of treatments: at least 5% change was seen only for the two most common subtypes of brachytherapy, HDR interstitial and HDR intracavitary, with an increase of 9.6% and a decrease of 9.2%, respectively. The use of other subtypes of brachytherapy (HDR-plesiotherapy, LDR-interstitial, LDR-intracavitary, LDR-eye plaque) was stable between 2011 and 2019, with ≤ 2.5% variation.
CONCLUSION: This study demonstrates an overall steady use of brachytherapy between 2011 and 2019 in Quebec. Brachytherapy offers numerous advantages for the treatment of diverse cancer sites. Although more sophisticated external beam radiotherapy treatments have emerged in the last decades, the precision and cost-effectiveness of brachytherapy remain unbeaten. To ensure the continued use and availability of brachytherapy, governments must put in place policies and regulations to that effect. Training and exposure of future health care professionals to brachytherapy within Quebec and Canada is essential to provide all patients the same access to this life saving modality.award
2021
Thibodeau-Antonacci, Alana; Vuong, Té; Bekerat, Hamed; Liang, Liheng; Enger, Shirin A.
2021.
Abstract | Links | BibTeX | Tags: Intensity Modulation, Intracavitary brachytherapy, Monte Carlo
@award{Thibodeau-Antonacci2021b,
title = {Development of a Dynamic Shielding Intensity-Modulated Brachytherapy Applicator for the Treatment of Rectal Cancer},
author = {Alana Thibodeau-Antonacci and Té Vuong and Hamed Bekerat and Liheng Liang and Shirin A. Enger},
url = {https://curietherapi.es/},
year = {2021},
date = {2021-05-23},
urldate = {2021-05-23},
organization = {Curietherapies},
abstract = {Oral presentation given online at the annual congress of Curietherapies https://curietherapi.es/},
howpublished = {Annual Congress of Curietherapies},
keywords = {Intensity Modulation, Intracavitary brachytherapy, Monte Carlo},
pubstate = {published},
tppubtype = {award}
}
Oral presentation given online at the annual congress of Curietherapies https://curietherapi.es/
Journal Articles
2021
Lecavalier-Barsoum, Magali; Khosrow-Khavar, Farzin; Asiev, Krum; Popovic, Marija; Vuong, Te; Enger, Shirin A.
Utilization of brachytherapy in Quebec, Canada Journal Article
In: Brachytherapy, pp. S1538–4721(21)00452–9, 2021, ISSN: 1873-1449.
Abstract | Links | BibTeX | Tags: High dose rate brachytherapy, Interstitial brachytherapy, Intracavitary brachytherapy, Low dose rate brachytherapy, Number of brachytherapy treatments, Trends in utilization
@article{lecavalier-barsoum_utilization_2021,
title = {Utilization of brachytherapy in Quebec, Canada},
author = {Magali Lecavalier-Barsoum and Farzin Khosrow-Khavar and Krum Asiev and Marija Popovic and Te Vuong and Shirin A. Enger},
doi = {10.1016/j.brachy.2021.07.002},
issn = {1873-1449},
year = {2021},
date = {2021-08-01},
journal = {Brachytherapy},
pages = {S1538--4721(21)00452--9},
abstract = {BACKGROUND AND PURPOSE: Despite the excellent clinical outcomes from brachytherapy treatments compared with other modalities and the low associated costs, there have been reports of a decline in utilization of brachytherapy. The aim of this study was to investigate in detail the trend in utilization of brachytherapy in the province of Québec, Canada, from 2011 to 2019.
MATERIALS AND METHODS: All radiotherapy clinics in the province of Quebec, and among these the clinics that provide brachytherapy treatments, were identified. This observational retrospective cohort study involved analysis of data compiled by the Ministère de la Santé et des Services Sociaux du Québec for the period of 2011 to end of 2019 on all brachytherapy procedures performed in the province of Quebec. Time series graphs were used to describe the number of high dose rate (HDR) and low dose rate (LDR) brachytherapy treatments during the studied time period. Statistical analysis was conducted using R statistical software.
RESULTS: Between 2011 and 2019, 12 hospitals in the province of Québec provided radiotherapy treatments, and all of them offered brachytherapy services. The median annual number of brachytherapy sessions was 4413 (range 3930-4829). HDR brachytherapy represented over 90% of all brachytherapy treatments throughout the study period. Significant changes over time were observed in the number of treatments: at least 5% change was seen only for the two most common subtypes of brachytherapy, HDR interstitial and HDR intracavitary, with an increase of 9.6% and a decrease of 9.2%, respectively. The use of other subtypes of brachytherapy (HDR-plesiotherapy, LDR-interstitial, LDR-intracavitary, LDR-eye plaque) was stable between 2011 and 2019, with ≤ 2.5% variation.
CONCLUSION: This study demonstrates an overall steady use of brachytherapy between 2011 and 2019 in Quebec. Brachytherapy offers numerous advantages for the treatment of diverse cancer sites. Although more sophisticated external beam radiotherapy treatments have emerged in the last decades, the precision and cost-effectiveness of brachytherapy remain unbeaten. To ensure the continued use and availability of brachytherapy, governments must put in place policies and regulations to that effect. Training and exposure of future health care professionals to brachytherapy within Quebec and Canada is essential to provide all patients the same access to this life saving modality.},
keywords = {High dose rate brachytherapy, Interstitial brachytherapy, Intracavitary brachytherapy, Low dose rate brachytherapy, Number of brachytherapy treatments, Trends in utilization},
pubstate = {published},
tppubtype = {article}
}
BACKGROUND AND PURPOSE: Despite the excellent clinical outcomes from brachytherapy treatments compared with other modalities and the low associated costs, there have been reports of a decline in utilization of brachytherapy. The aim of this study was to investigate in detail the trend in utilization of brachytherapy in the province of Québec, Canada, from 2011 to 2019.
MATERIALS AND METHODS: All radiotherapy clinics in the province of Quebec, and among these the clinics that provide brachytherapy treatments, were identified. This observational retrospective cohort study involved analysis of data compiled by the Ministère de la Santé et des Services Sociaux du Québec for the period of 2011 to end of 2019 on all brachytherapy procedures performed in the province of Quebec. Time series graphs were used to describe the number of high dose rate (HDR) and low dose rate (LDR) brachytherapy treatments during the studied time period. Statistical analysis was conducted using R statistical software.
RESULTS: Between 2011 and 2019, 12 hospitals in the province of Québec provided radiotherapy treatments, and all of them offered brachytherapy services. The median annual number of brachytherapy sessions was 4413 (range 3930-4829). HDR brachytherapy represented over 90% of all brachytherapy treatments throughout the study period. Significant changes over time were observed in the number of treatments: at least 5% change was seen only for the two most common subtypes of brachytherapy, HDR interstitial and HDR intracavitary, with an increase of 9.6% and a decrease of 9.2%, respectively. The use of other subtypes of brachytherapy (HDR-plesiotherapy, LDR-interstitial, LDR-intracavitary, LDR-eye plaque) was stable between 2011 and 2019, with ≤ 2.5% variation.
CONCLUSION: This study demonstrates an overall steady use of brachytherapy between 2011 and 2019 in Quebec. Brachytherapy offers numerous advantages for the treatment of diverse cancer sites. Although more sophisticated external beam radiotherapy treatments have emerged in the last decades, the precision and cost-effectiveness of brachytherapy remain unbeaten. To ensure the continued use and availability of brachytherapy, governments must put in place policies and regulations to that effect. Training and exposure of future health care professionals to brachytherapy within Quebec and Canada is essential to provide all patients the same access to this life saving modality.
MATERIALS AND METHODS: All radiotherapy clinics in the province of Quebec, and among these the clinics that provide brachytherapy treatments, were identified. This observational retrospective cohort study involved analysis of data compiled by the Ministère de la Santé et des Services Sociaux du Québec for the period of 2011 to end of 2019 on all brachytherapy procedures performed in the province of Quebec. Time series graphs were used to describe the number of high dose rate (HDR) and low dose rate (LDR) brachytherapy treatments during the studied time period. Statistical analysis was conducted using R statistical software.
RESULTS: Between 2011 and 2019, 12 hospitals in the province of Québec provided radiotherapy treatments, and all of them offered brachytherapy services. The median annual number of brachytherapy sessions was 4413 (range 3930-4829). HDR brachytherapy represented over 90% of all brachytherapy treatments throughout the study period. Significant changes over time were observed in the number of treatments: at least 5% change was seen only for the two most common subtypes of brachytherapy, HDR interstitial and HDR intracavitary, with an increase of 9.6% and a decrease of 9.2%, respectively. The use of other subtypes of brachytherapy (HDR-plesiotherapy, LDR-interstitial, LDR-intracavitary, LDR-eye plaque) was stable between 2011 and 2019, with ≤ 2.5% variation.
CONCLUSION: This study demonstrates an overall steady use of brachytherapy between 2011 and 2019 in Quebec. Brachytherapy offers numerous advantages for the treatment of diverse cancer sites. Although more sophisticated external beam radiotherapy treatments have emerged in the last decades, the precision and cost-effectiveness of brachytherapy remain unbeaten. To ensure the continued use and availability of brachytherapy, governments must put in place policies and regulations to that effect. Training and exposure of future health care professionals to brachytherapy within Quebec and Canada is essential to provide all patients the same access to this life saving modality.
award
2021
Thibodeau-Antonacci, Alana; Vuong, Té; Bekerat, Hamed; Liang, Liheng; Enger, Shirin A.
2021.
Abstract | Links | BibTeX | Tags: Intensity Modulation, Intracavitary brachytherapy, Monte Carlo
@award{Thibodeau-Antonacci2021b,
title = {Development of a Dynamic Shielding Intensity-Modulated Brachytherapy Applicator for the Treatment of Rectal Cancer},
author = {Alana Thibodeau-Antonacci and Té Vuong and Hamed Bekerat and Liheng Liang and Shirin A. Enger},
url = {https://curietherapi.es/},
year = {2021},
date = {2021-05-23},
urldate = {2021-05-23},
organization = {Curietherapies},
abstract = {Oral presentation given online at the annual congress of Curietherapies https://curietherapi.es/},
howpublished = {Annual Congress of Curietherapies},
keywords = {Intensity Modulation, Intracavitary brachytherapy, Monte Carlo},
pubstate = {published},
tppubtype = {award}
}
Oral presentation given online at the annual congress of Curietherapies https://curietherapi.es/